Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Lehrbeauftragte/r, Klinik für Urologie
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkersIn: Prostate Cancer and Prostatic Diseases, Jg. 28, 2025, Nr. 3, S. 773 – 781DOI (Open Access)
-
xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axisIn: PLoS ONE, Jg. 20, 2025, Nr. 1, e0318213DOI (Open Access)
-
Accelerating histopathology workflows with generative AI-based virtually multiplexed tumour profilingIn: Nature Machine Intelligence, Jg. 6, 2024, Nr. 9, S. 1077 – 1093DOI (Open Access)
-
Epiregulin expression and secretion is increased in castration-resistant prostate cancerIn: Frontiers in Oncology, Jg. 13, 2023, 1107021DOI, Online Volltext (Open Access)
-
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma : Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17In: Journal of Clinical Oncology (JCO), Jg. 41, 2023, Nr. 33, S. 5131 – 5139DOI (Open Access)
-
Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cellsIn: Frontiers in Oncology, Jg. 13, 2023, 1212585DOI, Online Volltext (Open Access)
-
High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancerIn: Prostate Cancer and Prostatic Diseases, Jg. 25, 2022, Nr. 3, S. 484 – 490DOI (Open Access)
-
Newly Diagnosed Oligometastatic Prostate Cancer : Current Controversies and Future DevelopmentsIn: European Urology Oncology, Jg. 5, 2022, Nr. 5, S. 587 – 600
-
Increased expression of akt3 in neuroendocrine differentiated prostate cancer cells alters the response towards anti‐androgen treatmentIn: Cancers, Jg. 13, 2021, Nr. 3, S. 578DOI, Online Volltext (Open Access)
-
Patient-derived xenografts and organoids model therapy response in prostate cancerIn: Nature Communications, Jg. 12, 2021, Nr. 1, S. 1117DOI (Open Access)
-
Small Molecular Inhibitors Block TRPM4 Currents in Prostate Cancer Cells, with Limited Impact on Cancer Hallmark FunctionsIn: Journal of Molecular Biology (JMB), Jg. 433, 2021, Nr. 17, 166665DOI (Open Access)
-
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityIn: Nature Communications, Jg. 11, 2020, Nr. 1, S. 5549DOI (Open Access)
-
MiR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivoIn: BMC Cancer, Jg. 19, 2019, Nr. 1, S. 627DOI (Open Access)
-
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratificationIn: BMC Cancer, Jg. 19, 2019, Nr. 1, S. 1216DOI (Open Access)
-
Behandlung des fortgeschrittenen Prostatakarzinoms : Eine interdisziplinäre EmpfehlungIn: Praxis: Schweizerische Rundschau für Medizin = Revue Suisse de Médecine, Jg. 107, 2018, Nr. 19, S. 1043 – 1051
-
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centersIn: The Journal of Clinical Endocrinology & Metabolism (JCEM), Jg. 95, 2010, Nr. 11, S. 4925 – 4932
-
Multiparametric Magnetic Resonance Imaging for Prostate-specific Antigen Recurrence After Radical Prostatectomy : Are We Leaving the “One Treatment Fits All Approach” and Moving Towards Personalized Imaging-guided Treatment?In: European Urology. Amsterdam: Elsevier, Jg. 73, 2018, Nr. 6, S. 888 – 889
-
Perioperative chemoimmunotherapy with durvalumab for operable muscle-invasive urothelial carcinoma (MIUC) : Primary analysis of the single arm phase II trial SAKK 06/17In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 40, 2022, Nr. 16_Suppl., S. 4515DOI (Open Access)
-
Management of Nonmetastatic Failure Following Local Prostate Cancer TherapyIn: Urologic Oncology / Merseburger, Axel S.; Burger, Maximilian. Cham: Springer International Publishing, 2019, S. 227 – 240